{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:23:01Z","timestamp":1787239381455,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T00:00:00Z","timestamp":1565481600000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003758","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa e ao Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico do Maranh\u00e3o","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003758","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ijpddr.2019.08.002","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T11:19:04Z","timestamp":1565608744000},"page":"101-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["The combination therapy of meglumine antimoniate and oxiranes (epoxy-\u03b1-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis"],"prefix":"10.1016","volume":"10","author":[{"given":"Luiz Filipe","family":"Gon\u00e7alves-Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Souza-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luzia Monteiro","family":"de Castro C\u00f4rtes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Barral","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo Ac\u00e1cio","family":"Santini Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Cysne-Finkelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Curty","family":"Lechuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saulo Cabral","family":"Bourguignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Almeida-Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e1tia","family":"da Silva Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor Francisco","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Roberto","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijpddr.2019.08.002_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004900","article-title":"Morinda citrifolia Linn. Reduces parasite load and modulates cytokines and extracellular matrix proteins in C57BL\/6 mice infected with Leishmania (Leishmania) amazonensis","volume":"10","author":"Almeida-Souza","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.pt.2006.09.004","article-title":"Leishmaniasis and poverty","volume":"22","author":"Alvar","year":"2006","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/clinids\/18.3.381","article-title":"Efficacy of a short course (10 days) of high-dose meglumine antimonate with or without interferon-gamma in treating cutaneous leishmaniasis in Guatemala","volume":"18","author":"Arana","year":"1994","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.ijpddr.2019.08.002_bib4","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1021\/jm900185q","article-title":"Molecular basis of antimony treatment in leishmaniasis","volume":"52","author":"Baiocco","year":"2009","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ijpddr.2019.08.002_bib5","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1128\/AAC.27.6.916","article-title":"Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate","volume":"27","author":"Berman","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/clinids\/10.3.560","article-title":"Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies","volume":"10","author":"Berman","year":"1988","journal-title":"Rev. Infect. Dis."},{"issue":"15","key":"10.1016\/j.ijpddr.2019.08.002_bib7","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1016\/j.bmc.2013.05.017","article-title":"Anticancer activity and SAR studies of substituted 1,4-naphthoquinones","volume":"21","author":"Bhasin","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijpddr.2019.08.002_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijantimicag.2014.10.023","article-title":"Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis","volume":"45","author":"Bhattacharjee","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"2","key":"10.1016\/j.ijpddr.2019.08.002_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1708-8305.2008.00286.x","article-title":"Treatment of cutaneous leishmaniasis in travelers 2009","volume":"16","author":"Blum","year":"2009","journal-title":"J. Travel Med."},{"issue":"3","key":"10.1016\/j.ijpddr.2019.08.002_bib10","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1021\/ic302175t","article-title":"Lawsone dimerization in cobalt(III) complexes toward the design of new prototypes of bioreductive prodrugs","volume":"52","author":"Bustamante","year":"2013","journal-title":"Inorg. Chem."},{"issue":"27","key":"10.1016\/j.ijpddr.2019.08.002_bib11","doi-asserted-by":"crossref","first-page":"20935","DOI":"10.1074\/jbc.M002418200","article-title":"Cloning of a novel inosineguanosine transporter gene from Leishmania donovani by functional rescue of a transport-deficient mutant","volume":"275","author":"Carter","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijpddr.2019.08.002_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.ijpddr.2019.08.002_bib13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0304-4165(02)00198-8","article-title":"Antimony(V) complex formation with adenine nucleosides in aqueous solution","volume":"1570","author":"Demicheli","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpddr.2019.08.002_bib14","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1016\/j.bmc.2006.04.046","article-title":"Trypanocidal agents with low cytotoxicity to mammalian cell line: a comparison of the theoretical and biological features of lapachone derivatives","volume":"14","author":"Ferreira","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jinorgbio.2007.10.010","article-title":"New insights into the chemical structure and composition of the pentavalent antimonial drugs, meglumine antimonate and sodium stibogluconate","volume":"102","author":"Fr\u00e9zard","year":"2008","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib16","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules14072317","article-title":"Pentavalent antimonials: new perspectives for old drugs","volume":"14","author":"Fr\u00e9zard","year":"2009","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ijpddr.2019.08.002_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jac\/40.2.287","article-title":"Efficacy of aminosidine administered alone or in combination with meglumine antimoniate for the treatment of experimental visceral leishmaniasis caused by Leishmania infantum","volume":"40","author":"Gangneux","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ejmech.2013.10.011","article-title":"Synthesis and biological evaluation of novel ferrocene-naphthoquinones as antiplasmodial agents","volume":"70","author":"Garc\u00eda-Barrantes","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"Griensven","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib20","author":"Health Ministry of Brazil, Department of Epidemiological Surveillance"},{"key":"10.1016\/j.ijpddr.2019.08.002_bib21","author":"Health Ministry of Brazil, Department of Epidemiological Surveillance"},{"issue":"5","key":"10.1016\/j.ijpddr.2019.08.002_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005620","article-title":"Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum","volume":"11","author":"Hendrickx","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1992.46.296","article-title":"Recommendations for treating Leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies","volume":"46","author":"Herwaldt","year":"1992","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.ijpddr.2019.08.002_bib24","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1007\/s00044-013-0806-y","article-title":"Nucleophilic substitution reactions of 1,4-naphthoquinone and biologic properties of novel S-, S,S-, N-, and N,S-substituted 1,4-naphthoquinone derivatives","volume":"23","author":"Ibis","year":"2014","journal-title":"Med. Chem. Res."},{"issue":"21","key":"10.1016\/j.ijpddr.2019.08.002_bib25","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.1021\/jm800499x","article-title":"Design and synthesis of a novel series of pyranonaphthoquinones as topoisomerase II catalytic inhibitors","volume":"51","author":"Jim\u00e9nez-Alonso","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00436-006-0153-8","article-title":"Oxyrane derivative of \u03b1-lapachone is potent growth inhibitor of Trypanosoma cruzi epimastigote forms","volume":"99","author":"Jorqueira","year":"2006","journal-title":"Parasitol. Res."},{"issue":"10","key":"10.1016\/j.ijpddr.2019.08.002_bib27","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2174\/18715206113139990096","article-title":"Chemoprevention of skin cancer: effect of Lawsonia inermis L. (Henna) leaf powder and its pigment artifact, lawsone in the Epstein- Barr virus early antigen activation assay and in two-stage mouse skin carcinogenesis models","volume":"13","author":"Kapadia","year":"2013","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"2","key":"10.1016\/j.ijpddr.2019.08.002_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.abb.2010.02.002","article-title":"1,4-Naphthoquinones as inducers of oxidative damage and stress signaling in HaCaT human keratinocytes","volume":"496","author":"Klaus","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"issue":"7","key":"10.1016\/j.ijpddr.2019.08.002_bib29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1590\/S0074-02762004000700017","article-title":"Antileishmanial activity of lapachol analogues","volume":"99","author":"Lima","year":"2004","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ijpddr.2019.08.002_bib30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1086\/513776","article-title":"Efficacy of sodium stibogluconate alone and in combination with allopurinol for treatment of mucocutaneous leishmaniasis","volume":"25","author":"Llanos-Cuentas","year":"1997","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.ijpddr.2019.08.002_bib31","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1128\/AAC.42.8.1990","article-title":"Sensitivity of Leishmania Viannia panamensis to pentavalent antimony is correlated with the formation of cleavable DNA-protein complexes","volume":"42","author":"Lucumi","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.ijpddr.2019.08.002_bib32","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10600-012-0094-7","article-title":"Synthesis and HIV-1 reverse transcriptase inhibition activity of 1,4-naphthoquinone derivatives","volume":"47","author":"Mahapatra","year":"2012","journal-title":"Chem. Nat. Compd."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib33","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJM199203123261105","article-title":"Allopurinol in the treatment of American cutaneous leishmaniasis","volume":"326","author":"Martinez","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/clinids\/24.2.165","article-title":"Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate","volume":"24","author":"Martinez","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib35","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1371\/journal.pntd.0000491","article-title":"First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony","volume":"3","author":"Miranda-Verastegui","year":"2009","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"23","key":"10.1016\/j.ijpddr.2019.08.002_bib36","doi-asserted-by":"crossref","first-page":"9530","DOI":"10.1021\/jm400978u","article-title":"Design, synthesis, and biological testing of novel naphthoquinones as substrate-based inhibitors of the quinol\/fumarate reductase from Wolinella succinogenes","volume":"56","author":"Nasiri","year":"2013","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ijpddr.2019.08.002_bib37","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/jop.12060","article-title":"Effects of lawsone methyl ether mouthwash on oral Candida in HIV-infected subjects and subjects with denture stomatitis","volume":"42","author":"Nittayananta","year":"2013","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the new world","volume":"118","author":"Oliveira","year":"2011","journal-title":"Acta Trop."},{"issue":"4","key":"10.1016\/j.ijpddr.2019.08.002_bib39","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/molecules23040864","article-title":"Antileishmanial activity of 2-methoxy-4H-spiro-[naphthalene-1,2\u2032-oxiran]-4-one (Epoxymethoxy-lawsone): a promising new drug candidate for leishmaniasis treatment","volume":"23","author":"Oliveira","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ijpddr.2019.08.002_bib40","doi-asserted-by":"crossref","first-page":"9840210","DOI":"10.1155\/2017\/9840210","article-title":"Evidence for tissue toxicity in BALB\/c exposed to a long-term treatment with oxiranes compared to meglumine antimoniate","volume":"2017","author":"Oliveira","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11101-016-9471-3","article-title":"Natural products and phytotherapy: an innovative perspective in leishmaniasis treatment","volume":"16","author":"Oliveira","year":"2017","journal-title":"Phytochem. Rev."},{"issue":"9","key":"10.1016\/j.ijpddr.2019.08.002_bib42","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.bmc.2013.03.002","article-title":"Synthesis and cytotoxic activity of metallic complexes of lawsone","volume":"21","author":"Oramas-Royo","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib43","series-title":"Leishmaniasis en las Am\u00e9ricas: recomendaciones para el tratamento","author":"Organizaci\u00f2n Panamericana de la Salud (OPAS)","year":"2013"},{"key":"10.1016\/j.ijpddr.2019.08.002_bib44","author":"Organizaci\u00f2n Panamericana de la Salud (OPAS)"},{"key":"10.1016\/j.ijpddr.2019.08.002_bib45","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1128\/AAC.48.9.3591-3593.2004","article-title":"Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB\/c mice","volume":"38","author":"Pal","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib46","doi-asserted-by":"crossref","first-page":"j3545","DOI":"10.1136\/bmj.j3545","article-title":"Drug resistance in malaria, tuberculosis, and HIV in South East Asia: biology, programme, and policy considerations","volume":"358","author":"Panda","year":"2017","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ijpddr.2019.08.002_bib47","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/jm060849b","article-title":"Synthesis and pharmacophore modeling of naphthoquinones derivatives with cytotoxic activity in human promyelocytic leucemia HL-60 cell line","volume":"50","author":"P\u00e9rez","year":"2007","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ijpddr.2019.08.002_bib48","doi-asserted-by":"crossref","first-page":"E170","DOI":"10.1073\/pnas.1210419110","article-title":"Defining principles of combination drug mechanisms of action","volume":"110","author":"Pritchard","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.ijpddr.2019.08.002_bib49","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/dnares\/dst031","article-title":"The genome sequence of Leishmania (Leishmania) amazonensis: functional annotation and extended analysis of gene models","volume":"20","author":"Real","year":"2013","journal-title":"DNA Res."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib50","first-page":"2344","volume":"vol. 1","author":"Sambrook","year":"2001"},{"key":"10.1016\/j.ijpddr.2019.08.002_bib51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev.mi.49.100195.001001","article-title":"The structure and replication of kinetoplast DNA","volume":"49","author":"Shapiro","year":"1995","journal-title":"Annu. Rev. Microbiol."},{"issue":"234","key":"10.1016\/j.ijpddr.2019.08.002_bib52","first-page":"1","article-title":"Biological evaluation of hydroxynaphthoquinones as anti-malarials","volume":"12","author":"Schuck","year":"2013","journal-title":"Malar. J."},{"issue":"1","key":"10.1016\/j.ijpddr.2019.08.002_bib53","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00436-011-2498-x","article-title":"Evaluation of plumbagin and its derivative as potential modulators of redox thiol metabolism of Leishmania parasite","volume":"110","author":"Sharma","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib54","article-title":"Synthesis, antibacterial and antifungal activity of 2-amino-1,4-naphthoquinone using silica-supported perchloric acid (HClO4-SiO2) as a mild recyclable and highly efficient heterogeneous catalyst","volume":"52B","author":"Sharma","year":"2013","journal-title":"Indian J. Chem."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib55","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2012.10.052","article-title":"Addition of thiols to o-quinone methide: new 2-hydroxy-3-phenylsulfanylmethyl[1,4]naphthoquinones and their activity against the human malaria parasite Plasmodium falciparum (3D7)","volume":"59","author":"Sharma","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.exppara.2014.10.002","article-title":"Evidences for leishmanicidal activity of the naphthoquinone derivative epoxy-\u03b1-lapachone","volume":"147","author":"Souza-Silva","year":"2014","journal-title":"Exp. Parasitol."},{"issue":"4","key":"10.1016\/j.ijpddr.2019.08.002_bib57","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1128\/AAC.04742-14","article-title":"Epoxy-\u03b1-lapachone has in vitro and in vivo anti-leishmania (Leishmania) amazonensis effects and inhibits serine proteinase activity in this parasite","volume":"59","author":"Souza-Silva","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ijpddr.2019.08.002_bib58","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1600-0714.2010.00921.x","article-title":"Antifungal activity of lawsone methyl ether in comparison with chlorhexidine","volume":"40","author":"Sritrairat","year":"2011","journal-title":"J. Oral Pathol. Med."},{"issue":"27","key":"10.1016\/j.ijpddr.2019.08.002_bib59","doi-asserted-by":"crossref","first-page":"25120","DOI":"10.1074\/jbc.M301975200","article-title":"Antimonial-induced increase in intracellular Ca2+ through non-selective cation channels in the host and the parasite is responsible for apoptosis of intracellular Leishmania donovani amastigotes","volume":"278","author":"Sudhandiran","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2019.08.002_bib60","series-title":"Control of Leishmaniases: Report of the Meeting of the WHO Expert Committee on the Control of Leishmaniases","author":"World Health Organization (WHO)","year":"2010"},{"key":"10.1016\/j.ijpddr.2019.08.002_bib61","author":"World Health Organization (WHO)"},{"issue":"38","key":"10.1016\/j.ijpddr.2019.08.002_bib62","doi-asserted-by":"crossref","first-page":"39925","DOI":"10.1074\/jbc.M405635200","article-title":"Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani","volume":"279","author":"Wyllie","year":"2004","journal-title":"J. Biol. Chem."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320719300715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320719300715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:48:26Z","timestamp":1761922106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320719300715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":62,"alternative-id":["S2211320719300715"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2019.08.002","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The combination therapy of meglumine antimoniate and oxiranes (epoxy-\u03b1-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2019.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}